Developing drugs for developing countries.
Publication
, Journal Article
Ridley, DB; Grabowski, HG; Moe, JL
Published in: Health Aff (Millwood)
2006
Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the developer to the manufacturer of a blockbuster drug. In a well-functioning market, the voucher would speed access to highly valued treatments. Thus, the voucher could benefit consumers in both developing and developed countries at relatively low cost to the taxpayer.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Health Aff (Millwood)
DOI
EISSN
2694-233X
Publication Date
2006
Volume
25
Issue
2
Start / End Page
313 / 324
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Reimbursement, Incentive
- Program Development
- Patents as Topic
- Orphan Drug Production
- Marketing
- Legislation, Drug
- Humans
- Health Services Accessibility
Citation
APA
Chicago
ICMJE
MLA
NLM
Ridley, D. B., Grabowski, H. G., & Moe, J. L. (2006). Developing drugs for developing countries. Health Aff (Millwood), 25(2), 313–324. https://doi.org/10.1377/hlthaff.25.2.313
Ridley, David B., Henry G. Grabowski, and Jeffrey L. Moe. “Developing drugs for developing countries.” Health Aff (Millwood) 25, no. 2 (2006): 313–24. https://doi.org/10.1377/hlthaff.25.2.313.
Ridley DB, Grabowski HG, Moe JL. Developing drugs for developing countries. Health Aff (Millwood). 2006;25(2):313–24.
Ridley, David B., et al. “Developing drugs for developing countries.” Health Aff (Millwood), vol. 25, no. 2, 2006, pp. 313–24. Pubmed, doi:10.1377/hlthaff.25.2.313.
Ridley DB, Grabowski HG, Moe JL. Developing drugs for developing countries. Health Aff (Millwood). 2006;25(2):313–324.
Published In
Health Aff (Millwood)
DOI
EISSN
2694-233X
Publication Date
2006
Volume
25
Issue
2
Start / End Page
313 / 324
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Reimbursement, Incentive
- Program Development
- Patents as Topic
- Orphan Drug Production
- Marketing
- Legislation, Drug
- Humans
- Health Services Accessibility